Prime Highlights:
- Morgan DeBaun, founder and CEO of Blavity Inc., is investing $100,000 in early-stage health startups over the next 90 days.
- She aims to support women-led and innovative health ventures while highlighting gaps in the current healthcare system.
Key Facts:
- DeBaun has previously been a quiet angel investor, backing only one or two startups a year with small checks.
- Her investment focus includes digital health apps, telehealth platforms, nutrition and food-as-medicine initiatives, and health data tools.
Background:
Morgan DeBaun, founder and CEO of Blavity Inc, has pledged to invest $100,000 in four early-stage health startups over the next 90 days, marking a public shift in her investment strategy.
DeBaun shared the announcement in a recent Substack post and on Instagram, saying she no longer plans to invest quietly. For years, she backed one or two startups annually as an angel investor without public statements. Now, she says, she wants to be more intentional and visible about where she puts her money.
The decision comes at a personal turning point. DeBaun recently turned 36 and is raising two children under the age of three while building companies with her husband. In her post, she described sitting in a doctor’s office and realizing she did not have a primary care physician because she lacked time. She said the situation was both embarrassing and common, highlighting problems in the current healthcare system.
DeBaun argues that the healthcare model in the United States focuses more on urgent treatment than prevention or long-term patient understanding. She believes technology, particularly artificial intelligence, can help close that gap. She believes in tools that help patients understand test results, connect diet to health, and reduce paperwork for doctors.
Her investment focus reflects that view. She plans to fund startups building digital health apps, AI-powered health tools, telehealth platforms, nutrition and food-as-medicine solutions, health data analytics products, and other consumer health innovations. She has emphasized that technology should reduce inequities in healthcare rather than deepen them.
Through AfroTech, the tech conference she founded, DeBaun has watched thousands of founders pitch their ideas. The event has grown from 650 attendees to 40,000 over the past decade. However, she says many early-stage health tech founders struggle to secure funding due to regulatory barriers and long development timelines.
With this new commitment, DeBaun aims to move beyond watching pitches and start writing checks, signaling stronger support for emerging health innovators.
